ADMET |
absorption: distribution, metabolism, excretion, toxicity |
AKT |
protein kinase B |
ALK |
anaplastic lymphoma kinase |
BFE |
binding free energy |
DFG |
Asp-Phe-Gly |
EGF |
epidermal growth factor |
FDA |
food and drug administration |
GF |
goodness of fit |
GFA |
genetic function approximation |
GH |
Güner-Henry |
GOLD |
genetic optimization for ligand docking |
GROMACS |
GROningen MAchine for Chemical Simulations |
HBD |
hydrogen bond donor |
HBA |
hydrogen bond acceptor |
Hy |
hydrophobic |
IC50
|
half maximal inhibitory concentration |
LINCS |
LINear Constraint Solver |
LUAD |
lung adenocarcinoma |
LUSC |
lung squamous cell carcinoma |
MD |
molecular dynamics |
MT |
mutant |
mTOR |
mammalian target of rapamycin |
MM/PBSA |
molecular mechanics/poisson-boltzmann surface area |
NI |
negative ionizable |
Nrf2 |
nuclear factor erythroid 2-related factor 2 |
NVT |
constant number of particles, volume and temperature |
NPT |
constant number of particles, pressure and temperature |
NSCLC |
non-small cell lung cancer |
PDB |
protein data bank |
PI |
positive ionizable |
PI3K |
phosphoinositide 3-kinase |
P-loop |
phosphate binding loop |
PME |
Particle mesh Ewald |
RA |
ring aromatic |
RTK |
receptor tyrosine kinase |
ROS-1 |
c-ros oncogene 1 |
Ro5 |
rule of five |
RMSD |
root mean square deviation |
VMD |
visual molecular dynamics |
WT |
wild-type |